Antisense Pharma is a biopharmaceutical company committed to researching, developing and marketing innovative medicines. Our drugs enable targeted treatment of aggressive tumor diseases. Our main objective is to extend the life expectancy of patients considerably and, at the same time, improve their quality of life.

Founded in 1998, the company is located at the BioPark in Regensburg – one of the most successful biotechnology centers in Germany. Our executive management has many years of entrepreneurial experience, expertise in the biopharmaceutical sector and a sound medical and scientific background. It is supported by a dedicated team with broad experience in the development, approval and marketing of new medicines.


Date Type Amount Investors Valuation
07/01/11 Other 11M MIG Funds, GAF Unknown